Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-039011
Filing Date
2017-06-09
Accepted
2017-06-09 19:08:14
Documents
1
Period of Report
2017-06-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3157
  Complete submission text file 0001209191-17-039011.txt   4698
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Issuer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PACIRA PHARMACEUTICALS, INC. 5 SYLVAN WAY PARSIPPANY NJ 07054
Business Address
Riker Lauren Bullaro (Reporting) CIK: 0001545439 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35060 | Film No.: 17904142